Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

09/02/2024 08:00

Feb 9 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2023        Dec 31, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            466 mln             699 mln                    
                 (-33.4 pct)        (+108.7 pct)                  
  Operating     loss 972 mln        loss 904 mln                  
  Recurring     loss 986 mln        loss 928 mln                  
  Net           loss 987 mln        loss 913 mln                  
  EPS           loss 4.68 yen       loss 4.74 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T